Kimberly-Clark's tissue sales surge 13%, suspends annual forecast

[April 22, 2020]   (Reuters) - Kimberly-Clark Corp <KMB.N> on Wednesday suspended its forecast for the year and said sales of tissue rose 13% in the first quarter as consumers stocked up in preparation for the coronavirus pandemic.

"A combination of increased consumer demand for our products and strong execution by our teams is reflected in our first quarter results," Chief Executive Officer Mike Hsu said in a statement.

Net sales for the three-months ended March 31 rose about 8% to $5.01 billion. Analysts were expecting sales of $4.89 billion, according to IBES data from Refinitiv.

(Reporting by Nivedita Balu in Bengaluru)

[© 2020 Thomson Reuters. All rights reserved.]

Copyright 2020 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.